| CAS Number | 1570496-34-2 |
| Catalog Number | AG01E6SU |
| Chemical Name | IACS 010759 - Bio-X |
| IUPAC Name | 5-[5-methyl-1-[[3-(4-methylsulfonylpiperidin-1-yl)phenyl]methyl]-1,2,4-triazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole |
| InChI | InChI=1S/C25H25F3N6O4S/c1-16-29-23(24-30-22(32-38-24)18-6-8-20(9-7-18)37-25(26,27)28)31-34(16)15-17-4-3-5-19(14-17)33-12-10-21(11-13-33)39(2,35)36/h3-9,14,21H,10-13,15H2,1-2H3 |
| InChI Key | HWJWNWZJUYCGKV-UHFFFAOYSA-N |
| MDL Number | MFCD30489429 |
| Molecular Formula | C25H25F3N6O4S |
| Molecular Weight | 562.5640 |
| SMILES | C(n1nc(nc1C)c1nc(no1)c1ccc(cc1)OC(F)(F)F)c1cc(ccc1)N1CCC(CC1)S(=O)(=O)C |
| Synonyms | IACS-010759,
1570496-34-2,
IACS-10759,
5-(5-methyl-1-(3-(4-(methylsulfonyl)piperidin-1-yl)benzyl)-1H-1,2,4-triazol-3-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole,
SCHEMBL15498716,
HWJWNWZJUYCGKV-UHFFFAOYSA-N,
BCP20596,
EX-A1907,
IACS 010759 - Bio-X,
AK549747,
HY-112037,
CS-0042459,
4-Methanesulfonyl-1-{3-[(5-methyl-3-{3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}-1H-1,2,4-triazol-1-yl)methyl]phenyl}piperidine,
|
| Complexity | 909 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 562.161g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 39 |
| Hydrogen Bond Acceptor Count | 12 |
| Hydrogen Bond Donor Count | 0 |
| Isotope Atom Count | 0 |
| Molecular Weight | 562.568g/mol |
| Monoisotopic Mass | 562.161g/mol |
| Rotatable Bond Count | 7 |
| Topological Polar Surface Area | 125A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 4.8 |
GHS Hazard and Precautionary Statements
| Symbol: | |
|
Hazard statements
|
|
|
Precautionary statements
|
|
Certificate of Analysis
Lot Number